Benjamin Wolozin, M.D., Ph.D., selected as next chair of CMND for 2013-2015
Benjamin Wolozin, M.D., Ph.D., was selected as the next chair of the National Institutes of Health Cellular and Molecular Biology of Neurodegeneration Study Section.
Dr. Wolozin is a professor in the Departments of Pharmacology & Experimental Therapeutics and Neurology, Principal Investigator of the Laboratory of Neurodegeneration and member of The Boston University Alzheimer’s Disease Center. For more information on Dr. Wolozin’s research, please visit his webpage here.
Congratulations, Dr. Wolozin!